DCOY earnings: a positive outcome, +38.8%

On May 12, 2022, Salarius Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +38.8% in the window around the event. It had already run -48.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.